Abstract
New therapeutic management of Alzheimer’s disease: interest to a phospholipase A2-targeted peptide able to cross the blood-brain barrier through the LDL receptor
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have